SynthesisAnnals of medicine2025

Cardiovascular safety of Janus kinase inhibitors in inflammatory bowel disease: a systematic review and network meta-analysis.

Huibin Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.